Moderna Biopharma Canada Corporation
Registration:
12
of
14
(2024-01-12
to
2024-02-14)
Policies or Program
- Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
- Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models
- The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada